Affiliation:
1. Federal Scientific Center of Hygiene named after F.F. Erisman of the Federal Service for Supervision in Protection of the Rights of Consumer and Man Wellbeing
2. Samara State Medical University
Abstract
Introduction. Occupational asthma has long been considered as a separate, independent disease, but in recent years, more and more attention is paid to its heterogeneity. Molecular genotyping opens up new possibilities in the search for a more targeted and personalized approach to the treatment of occupational asthma, and in the development of an individual strategy for its prevention.
The aim of the study was to determine genetic markers of the risk of developing occupational bronchial asthma under exposure to sensitizing substances by assessing polymorphic variants rs2069812 of the IL-5 gene and polymorphic variants rs1837253 of the TSLP gene.
Materials and methods. The study was conducted in one hundred seventy patients with various phenotypes of occupational bronchial asthma and 50 people in the control group. Genotyping was performed by real-time polymerase chain reaction using primers and probes developed using the PrimerQuest program (Intergrated DNA Technologies, Inc.).
Results. For the first time, genetic markers of the risk for occupational bronchial asthma under exposure to sensitizing substances were identified to include polymorphic variants rs2069812 of the IL-5 gene and polymorphic variants rs1837253 of the TSLP gene. It makes it possible to recommend the determination of these genetic markers during in-depth periodic medical examinations in people working under conditions of exposure to sensitizing and irritating substances in the presence of clinical and functional, immunological changes.
Limitations. The study has regional (Samara region) and occupational (detailed working conditions in the studied comparison groups) limitations.
Conclusion. The identified marker profiles of occupational asthma genotypes can optimize the approach to diagnosis, treatment, and prevention of this pathology, and expand the range of criteria for predicting the course of the disease.
Publisher
Federal Scientific Center for Hygiene F.F.Erisman
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health,Pollution,General Medicine
Reference19 articles.
1. Federal clinical guidelines. Professional bronchial asthma. Moscow; 2017. (in Russian)
2. GINA Report. Global Strategy for Asthma Management and Prevention. Available at: http://www.ginasthma.org
3. Nenasheva N.M. Phenotypes of bronchial asthma and the choice of therapy. Prakticheskaya pul’monologiya. 2014; (2): 2–11. (in Russian)
4. Kurbacheva O.M. Bronchial asthma. What can be done to achieve disease control. Rossiyskiy allergologicheskiy zhurnal. 2012; (2): 28–34. (in Russian)
5. Tilles S.A., Jerath-Tatum A. Differential diagnosis of occupational asthma. Immunol. Allergy Clin. N. Am. 2003; 23(2): 167–76. https://doi.org/10.1016/s0889-8561(02)00089-9